coronavirus vaccine

Stories 801 - 820 | << Prev   Next >>

New Vaccine Candidate Is Getting High Praise

One from Novavax 'is the first one I’m looking at and saying, ‘Yeah, I’d take that,' says virologist

(Newser) - Another coronavirus vaccine candidate is advancing in clinical trials, and the New York Times coverage about it carries this notable quote from a virologist: "This is the first one I’m looking at and saying, 'Yeah, I’d take that." The quote is from John Moore of...

Russia Will Start Mass COVID Vaccinations in October

Despite the fact that clinical trials are not yet complete

(Newser) - Clinical trials are not yet complete, but Russia plans to roll out a nationwide COVID-19 vaccination campaign in October. Teachers and health care workers will be the first to get the coronavirus vaccine currently being developed by Moscow's Gamaleya Institute, which is reportedly set to begin Phase III trials—...

Fauci: We Could Have Vaccine This Year
Fauci: We Could Have
Vaccine This Year
the rundown

Fauci: We Could Have Vaccine This Year

He's 'cautiously optimistic'

(Newser) - Dr. Anthony Fauci reaffirmed Friday that the first coronavirus vaccine could be available to Americans before the end of the year. "We hope that as ... we get into the late fall and early winter we will have, in fact, a vaccine that we can say would be safe and...

Trump Hails Vaccine Progress, Calls for States to Reopen

He predicts 'tremendous' recovery

(Newser) - President Trump hailed progress toward a coronavirus vaccine Monday, saying his administration's Operation Warp Speed had reduced development time by years. The project is a "historic initiative to develop, test, manufacture, and deliver a vaccine in record time," the president said during a visit to a North...

Biggest Vaccine Study Yet Gets Underway
Largest Vaccine Trial
Yet Gets Underway
the rundown

Largest Vaccine Trial Yet Gets Underway

About 30K volunteers will receive shots in tests by Moderna for a coronavirus vaccine

(Newser) - The early, small-scale testing is over, and now the largest trial to date for a COVID-19 vaccine is underway, reports the AP . This one involves the vaccine made by Moderna , and the first of 30,000 volunteers in the US will begin getting shots on Monday. Half will get the...

Don't Get Your Hopes Up for a Single-Dose Vaccine: Gates

Bill Gates says we'll likely need multiple doses

(Newser) - While scientists hoped to develop a coronavirus vaccine that would require just one dose, that does not appear to be likely, Bill Gates warned Wednesday. "None of the vaccines at this point appear like they'll work with a single dose," he told CBS Evening News . And "...

Operation Warp Speed Counts a Vaccine Win

Government will pay $1.95B for 100M doses, expected by year's end

(Newser) - The US has inked a deal that will have the country receiving the first 100 million doses of a coronavirus vaccine candidate in the works from Pfizer and German biotech firm BioNTech SE. The government could nab an additional 500 million doses under the agreement, which will see the US...

Surgeon General: Wearing Masks Now Will Help Schools
Surgeon General: We Can Do
One Big Thing for Schools
the rundown

Surgeon General: We Can Do One Big Thing for Schools

Lower the transmission rate by wearing masks

(Newser) - The surgeon general on Tuesday weighed in on the should-we-or-shouldn't-we debate over the reopening of schools. If we want to get students back into classrooms safely in the near future, everybody should be wearing masks now, Dr. Jerome Adams told CBS This Morning . "The biggest determinant of whether...

In Quest for COVID Vaccine, 107K 'Medical Heroes' Emerge

Volunteers coming out in droves to help 4 firms planning on starting phase 3 of clinical trials in fall

(Newser) - In early July, the National Institutes of Health launched a clinical trials network through which it hoped to enroll thousands of volunteers to test potential COVID-19 vaccines. Just a week or so later, more than 107,000 people had signed up. That's a number USA Today says will "...

Early Vaccine Tests at Oxford Show Promise

Those who got the shot developed antibodies

(Newser) - Researchers at Oxford University have hopeful—but very early—news to report about their coronavirus vaccine candidate. Those who got the shot in a small trial developed antibodies with no ill effects, they report in the Lancet medical journal. The BBC calls the results "hugely promising" but adds that...

One Company Is Giving Its Workers a Virus 'Vaccine'

'Giving a helping hand in forging the sword of victory,' reads a post from SinoPharm

(Newser) - In the global race to make a coronavirus vaccine, a state-owned Chinese company is boasting that its employees, including top executives, received experimental shots even before the government approved testing in people, the AP reports. "Giving a helping hand in forging the sword of victory," reads an online...

Fauci Hails Good News on Coronavirus Vaccine

Shots provided hoped-for immune boost

(Newser) - The first COVID-19 vaccine tested in the US revved up people’s immune systems just the way scientists had hoped, researchers reported Tuesday—as the shots are poised to begin key final testing. "No matter how you slice this, this is good news," Dr. Anthony Fauci, the government’...

'I Feel Fantastic,' COVID-19 Vaccine Volunteer Says

Woman in Seattle trial reports no major side effects but still wears a mask to be sure

(Newser) - The first person in the US to receive an experimental vaccine for COVID-19 has provided a medical update, and it's encouraging. "It's been 16 weeks since I had the first dose," Jennifer Haller says. "I feel fantastic." The Washington state woman, an operations manager...

Mutated Virus Now Dominates: Research

Vaccine development could be affected by change

(Newser) - Many uncertainties remain about the mutated form of the new coronavirus that has been under study as it quickly spreads. But one question about G614 has been resolved, researchers said Thursday. "This is now the virus," said Erica Ollmann Saphire, who worked on a study published in Cell...

Fauci Has Good News, Not as Good News on Vaccine

He says we should have hundreds of millions of doses by 2021, but how long will immunity last?

(Newser) - Dr. Anthony Fauci offered some hopeful comments Tuesday amid the coronavirus pandemic: By the end of the year, the US should have 100 million doses of one of the candidate COVID-19 vaccines, he said during a live Q&A. "Then, by the beginning of 2021, we hope to have...

Vaccine May Turn MIT Prof Into a Billionaire
Vaccine May Turn
MIT Prof Into a Billionaire
in case you missed it

Vaccine May Turn MIT Prof Into a Billionaire

Bob Langer has a stake in Moderna

(Newser) - Drug-maker Moderna reported good news Monday about a potential COVID-19 vaccine currently being tested. It was also good news—you might even say great news—for an MIT professor who owns a stake in the company. Bloomberg reports that Bob Langer's piece of the pie is now worth nearly...

Oxford Coronavirus Vaccine Will Be Tested on 10K People

Subjects will include older people, children

(Newser) - British researchers testing an experimental coronavirus vaccine are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works. Last month, scientists at Oxford University began immunizing more than 1,000 volunteers with their vaccine candidate in a preliminary trial designed to...

Dow Surges 963 Points After Encouraging Vaccine Results

Markets had their best day since early April

(Newser) - The stock market bounced back from its worst week in nearly two months Monday as optimism about a potential vaccine for the coronavirus and hopes for a US economic recovery in the second half of the year put investors in a buying mood. The S&P 500 climbed 3.2%,...

Vaccine Results Expected to Give Stock Market a Lift

Dow futures jump 650 points, in part on good news from Moderna trials

(Newser) - The stock market is expected to get off to a strong start on Monday after last week's struggles. Dow futures jumped 650 points, nearly 3%, and part of the reason is a promising report from drug-maker Moderna about a coronavirus vaccine, reports CNBC . The company says its vaccine contender...

Get Used to Life Like This, Leaders Tell Europeans

Conte, Johnson advise their nations not to count on a vaccine

(Newser) - In separate, stark warnings, two major European leaders have bluntly told their citizens that the world needs to adapt to living with the coronavirus and cannot wait to be saved by a vaccine. Italian Prime Minister Giuseppe Conte, pushed by his nation's regional leaders and weeks ahead of an...

Stories 801 - 820 | << Prev   Next >>